12 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
Zirconia Block
FDA 510(k)
FDA Class 2
·Dental
APEX PS Knee
FDA UDI
Omni Life Science, Inc.·00841690113768·PS-C Insert, Size 5 x 20mm
Sklar®
FDA UDI
SKLAR CORPORATION·10649111157295·GOLDMAN-FOX SCISS 5" CVD SERR
FlexiNylon cartridges Light Red
FDA UDI
PERFLEX LTD·07290110506629·5 identical cartridges sealed in a vacuum bag ;...
Gold Anchor
FDA UDI
Naslund Medical AB·07340145700988·22G (0.7mm) 25 cm needle with 0.40x20 mm marker
DIGITAL THERMOMTER
FDA 510(k)
FDA Class 2
·General Hospital
U2 ACETABULAR CUP
FDA 510(k)
FDA Class 2
·Orthopedic
Ambassador Cervical Plate System
FDA UDI
Choice Spine, LP·00840996161053·AMBASSADOR,DRILL,2.5x20
SAFETY FLEX CUFFED
FDA Adverse Event
Injury
·COVIDIEN, FORMERLY TYCO HEATLHCARE·Product code BTR·November 6, 2008
ONETOUCHPING GLUCOSEMGMTSYSTEM
FDA Adverse Event
Malfunction
·ANIMAS CORPORATION·Product code LZG·August 25, 2011
LEAD MODEL 302
FDA Adverse Event
Injury
·CYBERONICS INC·Product code LYJ·July 12, 2013
Brand Name: SenTiva" Product Name: VNS Therapy" SenTiva", Model 1000 Model/Catalog Number: 1000 Software Version: NA Product Description: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000 Generator was commercially approved for distribution in the U.S. on October 3, 2017 via PMA P970003/S210. Component: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS).
FDA Enforcement
Class II
·Ongoing·LivaNova USA, Inc.·February 5, 2025